Matches in SemOpenAlex for { <https://semopenalex.org/work/W1524381114> ?p ?o ?g. }
- W1524381114 endingPage "3979" @default.
- W1524381114 startingPage "3974" @default.
- W1524381114 abstract "Age is an important prognostic parameter, especially in patients with advanced high-grade non-Hodgkin's lymphoma (HG-NHL) who require more intensive and extensive therapy for any possible chance of cure. We investigated the potential of granulocyte colony-stimulating factor (G-CSF ) for reducing myelotoxicity, which is the most important dose-limiting factor for chemotherapy. Between March 1993 and June 1995, 158 previously untreated patients 60 years and older with HG-NHL were included in a cooperative randomized comparative trial and treated with a combination therapy including VNCOP-B (cyclophosphamide, mitoxantrone, vincristine, etoposide, bleomycin, and prednisone) with or without G-CSF. G-CSF was administered at 5 μg/kg/d throughout the treatment starting on day 3 of every week for 5 consecutive days. Of the 158 patients registered for the trial, 149 patients were evaluable: 77 received VNCOP-B plus G-CSF and 72 received VNCOP-B alone. The overall response rate was 81.5%, with complete response in 59%: 60% in the VNCOP-B plus G-CSF group, and 58% in the VNCOP-B group. At 30 months (median 24 months), 68% of all complete responders were alive without disease in the G-CSF group and 65% in the control group. Neutropenia occurred in 18 out of 77 (23%) of the G-CSF treated patients and in 40 out of 72 (55.5%) of the controls ( P = .00005). Clinically relevant infections occurred in 4 out of 77 (5%) of the G-CSF group and in 15 out of 72 (21%) of the controls ( P = .004). The delivered dose intensity was higher in patients receiving G-CSF (95% v 85%), but the difference was not statistically significant. Our data show that VNCOP-B is a feasible and effective regimen in elderly HG-NHL patients, and that the use of G-CSF reduces infection and neutropenia rates without producing any significant modifications to the dose intensity, CR rate, and relapse-free survival curve." @default.
- W1524381114 created "2016-06-24" @default.
- W1524381114 creator A5000093989 @default.
- W1524381114 creator A5004888416 @default.
- W1524381114 creator A5005495487 @default.
- W1524381114 creator A5008077055 @default.
- W1524381114 creator A5008693201 @default.
- W1524381114 creator A5013975790 @default.
- W1524381114 creator A5016603192 @default.
- W1524381114 creator A5028241549 @default.
- W1524381114 creator A5029563827 @default.
- W1524381114 creator A5033359713 @default.
- W1524381114 creator A5041681722 @default.
- W1524381114 creator A5045339988 @default.
- W1524381114 creator A5046307290 @default.
- W1524381114 creator A5051820054 @default.
- W1524381114 creator A5063235996 @default.
- W1524381114 creator A5072830858 @default.
- W1524381114 creator A5078922292 @default.
- W1524381114 creator A5082960835 @default.
- W1524381114 creator A5091882595 @default.
- W1524381114 date "1997-06-01" @default.
- W1524381114 modified "2023-09-28" @default.
- W1524381114 title "Randomized trial with or without granulocyte colony-stimulating factor as adjunct to induction VNCOP-B treatment of elderly high-grade non-Hodgkin's lymphoma." @default.
- W1524381114 cites W103650626 @default.
- W1524381114 cites W1519481201 @default.
- W1524381114 cites W1529388857 @default.
- W1524381114 cites W1880028535 @default.
- W1524381114 cites W1899541887 @default.
- W1524381114 cites W1905145727 @default.
- W1524381114 cites W1911079819 @default.
- W1524381114 cites W1911120442 @default.
- W1524381114 cites W1924320258 @default.
- W1524381114 cites W1944772631 @default.
- W1524381114 cites W1948967656 @default.
- W1524381114 cites W1950143877 @default.
- W1524381114 cites W1970938866 @default.
- W1524381114 cites W1973980594 @default.
- W1524381114 cites W1979300931 @default.
- W1524381114 cites W2000015872 @default.
- W1524381114 cites W2007345078 @default.
- W1524381114 cites W2011581612 @default.
- W1524381114 cites W201280849 @default.
- W1524381114 cites W2016995945 @default.
- W1524381114 cites W2043725893 @default.
- W1524381114 cites W2073151455 @default.
- W1524381114 cites W2075679917 @default.
- W1524381114 cites W2076668534 @default.
- W1524381114 cites W2092253409 @default.
- W1524381114 cites W2123678937 @default.
- W1524381114 cites W2129214379 @default.
- W1524381114 cites W2158027566 @default.
- W1524381114 cites W2174428418 @default.
- W1524381114 cites W2241705187 @default.
- W1524381114 cites W2257556319 @default.
- W1524381114 cites W2267575411 @default.
- W1524381114 cites W2307303548 @default.
- W1524381114 cites W2318772898 @default.
- W1524381114 cites W2346039614 @default.
- W1524381114 cites W2414592523 @default.
- W1524381114 cites W2416501851 @default.
- W1524381114 cites W2416693714 @default.
- W1524381114 cites W2417820555 @default.
- W1524381114 cites W2605539363 @default.
- W1524381114 cites W2468177196 @default.
- W1524381114 cites W2995133996 @default.
- W1524381114 doi "https://doi.org/10.1182/blood.v89.11.3974" @default.
- W1524381114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9166835" @default.
- W1524381114 hasPublicationYear "1997" @default.
- W1524381114 type Work @default.
- W1524381114 sameAs 1524381114 @default.
- W1524381114 citedByCount "75" @default.
- W1524381114 countsByYear W15243811142012 @default.
- W1524381114 countsByYear W15243811142013 @default.
- W1524381114 countsByYear W15243811142014 @default.
- W1524381114 countsByYear W15243811142015 @default.
- W1524381114 countsByYear W15243811142016 @default.
- W1524381114 countsByYear W15243811142017 @default.
- W1524381114 countsByYear W15243811142018 @default.
- W1524381114 countsByYear W15243811142019 @default.
- W1524381114 crossrefType "journal-article" @default.
- W1524381114 hasAuthorship W1524381114A5000093989 @default.
- W1524381114 hasAuthorship W1524381114A5004888416 @default.
- W1524381114 hasAuthorship W1524381114A5005495487 @default.
- W1524381114 hasAuthorship W1524381114A5008077055 @default.
- W1524381114 hasAuthorship W1524381114A5008693201 @default.
- W1524381114 hasAuthorship W1524381114A5013975790 @default.
- W1524381114 hasAuthorship W1524381114A5016603192 @default.
- W1524381114 hasAuthorship W1524381114A5028241549 @default.
- W1524381114 hasAuthorship W1524381114A5029563827 @default.
- W1524381114 hasAuthorship W1524381114A5033359713 @default.
- W1524381114 hasAuthorship W1524381114A5041681722 @default.
- W1524381114 hasAuthorship W1524381114A5045339988 @default.
- W1524381114 hasAuthorship W1524381114A5046307290 @default.
- W1524381114 hasAuthorship W1524381114A5051820054 @default.
- W1524381114 hasAuthorship W1524381114A5063235996 @default.
- W1524381114 hasAuthorship W1524381114A5072830858 @default.
- W1524381114 hasAuthorship W1524381114A5078922292 @default.